Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Tashkin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Chest|May 13, 2003
Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responsesDonald Tashkin, Steven Kesten
Current Opinion in Pulmonary Medicine|January 9, 2023
Recent advances predict a bright future for nebulizersMichael Troy, Joseph Van Vleet, Donald Tashkin, et al.
Respiratory Research|September 30, 2011
Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trialSteven Kesten, Bartolome Celli, Marc Decramer, et al.
Respiratory Medicine|April 27, 2010
Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trialDonald Tashkin, Bartolome Celli, Steven Kesten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 29, 2009
Tiotropium HandiHaler in the treatment of COPD: a safety reviewSteven Kesten, Bart Celli, Marc Decramer, et al.
Toxicology Letters|July 18, 2002
Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisoleTheodore A Sarafian, Shaghig Kouyoumjian, Donald Tashkin, et al.
Expert Review of Respiratory Medicine|August 4, 2019
The effect of e-cigarette aerosol emissions on respiratory health: a narrative reviewRiccardo Polosa, Renée O'Leary, Donald Tashkin, et al.
Respiratory Research|May 9, 2021
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levelsDaniel J Weiss, Karen Segal, Richard Casaburi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysisDavid Mg Halpin, Ronald Dahl, Christoph Hallmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Quality of life of long-term survivors of non-small-cell lung cancerLinda Sarna, Geraldine Padilla, Carmack Holmes, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Chest|May 13, 2003
Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responsesDonald Tashkin, Steven Kesten
Current Opinion in Pulmonary Medicine|January 9, 2023
Recent advances predict a bright future for nebulizersMichael Troy, Joseph Van Vleet, Donald Tashkin, et al.
Respiratory Research|September 30, 2011
Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trialSteven Kesten, Bartolome Celli, Marc Decramer, et al.
Respiratory Medicine|April 27, 2010
Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trialDonald Tashkin, Bartolome Celli, Steven Kesten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 29, 2009
Tiotropium HandiHaler in the treatment of COPD: a safety reviewSteven Kesten, Bart Celli, Marc Decramer, et al.
Toxicology Letters|July 18, 2002
Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisoleTheodore A Sarafian, Shaghig Kouyoumjian, Donald Tashkin, et al.
Expert Review of Respiratory Medicine|August 4, 2019
The effect of e-cigarette aerosol emissions on respiratory health: a narrative reviewRiccardo Polosa, Renée O'Leary, Donald Tashkin, et al.
Respiratory Research|May 9, 2021
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levelsDaniel J Weiss, Karen Segal, Richard Casaburi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysisDavid Mg Halpin, Ronald Dahl, Christoph Hallmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Quality of life of long-term survivors of non-small-cell lung cancerLinda Sarna, Geraldine Padilla, Carmack Holmes, et al.
Pageof 5